This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
and an investigator in the VIVID study , which contributed to the device’s FDA approval – successfully used the Duo Venous Stent System for the first time outside of a clinical trial. Duo Hybrid has a distinct integrated design that combines multiple zones of differing mechanical properties into a single stent [3].
milla1cf Mon, 05/06/2024 - 10:55 May 6, 2024 — SMT (Sahajanand Medical Technologies), a leading medical device company at the forefront of innovative patientcare in the cardiovascular segment has announced a strategic partnership with HeartX , a pioneering MedTech company focused on research and development.
Deep learning also assisted in surgical procedures by accurately predicting stent placement and postoperative complications. Furthermore, models were able to predict AA progression and patient prognosis with high accuracy.
In today’s fast-paced medical world, keeping up with the latest techniques and technologies is no longer a luxury for healthcare professionals it’s a necessity. At ADN Center of Excellence , we recognize that practical, experiential learning is vital for enhancing procedural expertise and improving patient outcomes.
In today’s fast-paced medical world, keeping up with the latest techniques and technologies is no longer a luxury for healthcare professionals it’s a necessity. At ADN Center of Excellence , we recognize that practical, experiential learning is vital for enhancing procedural expertise and improving patient outcomes.
By enabling the decisive shift from a reactive to a proactive cardiology model, this technology doesnt just improve patient outcomes it is also helping keep cardiovascular care sustainable and affordable. These costs represent a massive portion of total health expenditures. At the heart of AIs impact on cardiology?
narrates and is a co-producer of a documentary focused on radiation and orthopedic injuries suffered by doctors and nurses who work in cardiac catheterization laboratories where they apply the very latest non-surgical technologies to treat the world’s leading cause of death, heart disease. Rizik , M.D.,
Staying informed about these cutting-edge developments is critical for providing exceptional patientcare. Join us as we examine the landmark approvals that are revolutionizing patient outcomes.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content